You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Argentina Patent: 080368


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 080368

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 24, 2030 Lab Salvat OTOVEL ciprofloxacin hydrochloride; fluocinolone acetonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Analysis of AR080368: Scope, Claims, and Landscape

Last updated: February 20, 2026

What is the scope of patent AR080368?

Patent AR080368 was granted in Argentina and relates to a pharmaceutical invention. The patent’s scope covers specific chemical entities, formulations, or methods of use described in its claims. While detailed claims are necessary to assess full scope, typical parameters include:

  • The composition of matter: It likely involves a specific active pharmaceutical ingredient (API) or a combination thereof.
  • Formulation features: It may specify a dosage form, for example, tablets, capsules, or injectable forms.
  • Therapeutic application: It may specify the medical indication or method of treatment.

Details such as chemical structures, process steps, and specific claims are critical in evaluating scope, but are not available without the patent document's full text.

What are the key claims of AR080368?

Since the patent claims define the legal boundary of protection, their wording and breadth determine enforceability and competitive impact. The claims generally fall into categories:

  • Composition claims: Cover specific compounds or mixtures.
  • Use claims: Cover methods of treatment using the compound(s).
  • Process claims: Cover production methods.

Without access to the patent’s full specification and claims, a precise analysis cannot be conducted. In typical pharmaceutical patents, broad claims may encompass multiple derivatives or formulations, while narrower claims focus on specific chemical modifications or uses.

How does patent AR080368 fit into the global patent landscape?

Arkansas’s patent landscape reveals whether the patent:

  • Overlaps with international patents: Patent families filed in other jurisdictions, such as the US, Europe, or PCT, indicate broader protection strategies.
  • Complements existing patents: It may build upon prior patents by defining new uses, formulations, or chemical modifications.
  • Faces potential infringement or invalidation risks: Overlapping claims with earlier patents could threaten enforceability.

A comprehensive landscape analysis includes:

  • Patent family searches: Using databases such as Lens.org, Patentscope, or EPO Espacenet to identify related filings.
  • Prior art analysis: Comparing claims to existing patents and scientific literature to assess novelty and inventive step.
  • Citation analysis: Examining forward and backward citations to understand technological evolution.

What is the patent landscape for similar compounds or therapeutic classes?

The Argentine pharmaceutical patent landscape features key trends:

  • Active ingredients: Commonly patented classes include biologics, small molecules, and novel formulations.
  • Leading companies: Multinational corporations dominate filings, alongside local players.
  • Patent longevity: The patent term is typically 20 years from the earliest filing date, adjusted by patent term extension where applicable.

In Argentina, the patent examination process often emphasizes novelty and inventive step aligned with the patent Act No. 24,481. Patent filings for pharmaceutical active ingredients are scrutinized, but local patent law allows patenting of new uses and formulations, provided they meet criteria.

Specifics of Argentina patent law impacting AR080368

Argentina’s patent law permits patenting pharmaceuticals that meet requirements of novelty, inventive step, and industrial applicability. Critical points include:

  • Exclusions: Naturally occurring substances and methods of medical treatment are excluded.
  • Data requirements: Clear description and enablement are necessary.
  • Patent term: 20 years from the filing date, subject to procedural delays.

The patent’s enforceability depends on compliance with these requirements and whether it adequately discloses the invention.

Summary of relevant legal and commercial considerations

  • It is essential to compare patent claims with existing patents to verify the scope.
  • Analyzing patent family breadth can reveal potential for extension into other jurisdictions.
  • The patent’s actual enforceability depends on whether the claims are sufficiently precise and novel under Argentine law.

Key Takeaways

  • Fully assessing patent scope and claims requires access to the patent document.
  • The patent landscape is dynamic, with related filings possibly in multiple jurisdictions.
  • Argentine law allows patenting of chemical inventions, but exclusions might impact scope.
  • Patent validity depends on novelty, inventive step, and sufficient disclosure.
  • Due diligence should include prior art searches, claim interpretation, and jurisdictional analysis.

5 FAQs

1. How can I determine the exact chemical scope of AR080368?
Review the full patent claims and description, typically available in the official patent office or through patent databases.

2. Are method-of-use patents enforceable in Argentina?
Yes, if claims clearly specify the method in a manner that meets Argentine patent law criteria.

3. Does Argentina recognize patent term extensions for pharmaceuticals?
No; the standard term is 20 years from the filing date, with extensions not typically granted.

4. Can similar patents be filed in Argentina for related compounds?
Yes, if the new compounds or uses are sufficiently inventive and disclose novel features.

5. What is the likelihood of patent infringement if an identical compound is marketed in Argentina?
High if the patent claims cover the compound or its use; detailed claim analysis is required for certainty.


References

  1. Argentine Patent Law No. 24,481 (1986).
  2. World Intellectual Property Organization. (2022). Patent landscape analysis for pharmaceuticals.
  3. Espacenet. Patent data for Argentina.
  4. Lens.org. Patent family and citation analysis tools.
  5. Patent Office of Argentina. Official patent documentation portal.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.